Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/21739
Title: PACS Integration of Semiautomated Imaging Software Improves Day-to-Day MS Disease Activity Detection.
Authors: Dahan, Ariel;Pereira, R;Malpas, C B;Kalincik, T;Gaillard, F
Affiliation: Department of Radiology, Austin Health, Heidelberg, Victoria, Australia
Departments of Radiology and Neurology, Royal Melbourne Hospital, Parkville, Victoria, Australia
Clinical Outcomes Research Unit (CORe), Departments of Medicine and Radiology, University of Melbourne, Melbourne, Australia
Department of Radiology, University of Queensland, Brisbane, Queensland, Australia
Issue Date: 12-Sep-2019
EDate: 2019-09-12
Citation: AJNR. American journal of neuroradiology 2019; online first: 12 September
Abstract: The standard for evaluating interval radiologic activity in MS, side-by-side MR imaging comparison, is restricted by its time-consuming nature and limited sensitivity. VisTarsier, a semiautomated software for comparing volumetric FLAIR sequences, has shown better disease-activity detection than conventional comparison in retrospective studies. Our objective was to determine whether implementing this software in day-to-day practice would show similar efficacy. VisTarsier created an additional coregistered image series for reporting a color-coded disease-activity change map for every new MS MR imaging brain study that contained volumetric FLAIR sequences. All other MS studies, including those generated during software-maintenance periods, were interpreted with side-by-side comparison only. The number of new lesions reported with software assistance was compared with those observed with traditional assessment in a generalized linear mixed model. Questionnaires were sent to participating radiologists to evaluate the perceived day-to-day impact of the software. Nine hundred six study pairs from 538 patients during 2 years were included. The semiautomated software was used in 841 study pairs, while the remaining 65 used conventional comparison only. Twenty percent of software-aided studies reported having new lesions versus 9% with standard comparison only. The use of this software was associated with an odds ratio of 4.15 for detection of new or enlarging lesions (P = .040), and 86.9% of respondents from the survey found that the software saved at least 2-5 minutes per scan report. VisTarsier can be implemented in real-world clinical settings with good acceptance and preservation of accuracy demonstrated in a retrospective environment.
URI: http://ahro.austin.org.au/austinjspui/handle/1/21739
DOI: 10.3174/ajnr.A6195
ORCID: 0000-0003-3205-425X
0000-0002-7965-2065
0000-0003-0534-3718
0000-0003-3778-1376
0000-0002-2382-872X
PubMed URL: 31515214
Type: Journal Article
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.